I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Treatment-related adverse events:
Machiko Kai
;
Hayato Hikita
;
Maesaka Kazuki
...
doi:10.1371/journal.pone.0294590.t004. , 2024
Link:
https://doi.org/10.1371/journal.pone.0294590.t004
RT Journal T1
Treatment-related adverse events
UL https://suche.suub.uni-bremen.de/peid=base-ftdeakinunifig:oai:figshare.com:article_24928238&Exemplar=1&LAN=DE A1 Machiko Kai A1 Hayato Hikita A1 Maesaka Kazuki A1 Yuki Tahata A1 Kazuma Shinkai A1 Akira Doi A1 Kazuyoshi Ohkawa A1 Masanori Miyazaki A1 Hisashi Ishida A1 Kengo Matsumoto A1 Yasutoshi Nozaki A1 Takayuki Yakushijin A1 Ryotaro Sakamori A1 Akira Kaneko A1 Sadaharu Iio A1 Takatoshi Nawa A1 Naruyasu Kakita A1 Naoki Morishita A1 Naoki Hiramatsu A1 Takeo Usui A1 Kazuho Imanaka A1 Yoshinori Doi A1 Mitsuru Sakakibara A1 Yuichi Yoshida A1 Tsugiko Oze A1 Takahiro Kodama A1 Tomohide Tatsumi A1 Tetsuo Takehara YR 2024 K1 Ecology K1 Immunology K1 Cancer K1 Science Policy K1 Biological Sciences not elsewhere classified K1 unresectable hepatocellular carcinoma K1 severe adverse events K1 objective response rate K1 independent risk factors K1 grade &# 8805 K1 disease control rate K1 clinical factors associated K1 atezolizumab plus bevacizumab K1 absent macrovascular invasion K1 9 months vs K1 6 % K1 respectively K1 3 months vs K1 0 months vs K1 shortened overall survival K1 median overall survival K1 8 months ) K1 7 months ) K1 overall survival K1 7 months K1 free survival K1 6 ) K1 shortened progression K1 median progression K1 xlink "> K1 world practice K1 study aimed K1 older age K1 lymphocyte ratio K1 lower number K1 lower neutrophil K1 intrahepatic tumors K1 higher number K1 higher neutrophil K1 75 years K1 400 ng K1 19 hospitals K1 03 ) K1 0 %) JF doi:10.1371/journal.pone.0294590.t004 LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0294590.t004 DO https://doi.org/10.1371/journal.pone.0294590.t004 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)